Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Liabilities and Shareholders Equity (2016 - 2025)

Mesa Laboratories (MLAB) has disclosed Liabilities and Shareholders Equity for 15 consecutive years, with $434.8 million as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity changed 0.35% to $434.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.7 billion through Dec 2025, down 2.27% year-over-year, with the annual reading at $433.3 million for FY2025, 3.01% down from the prior year.
  • Liabilities and Shareholders Equity hit $434.8 million in Q4 2025 for Mesa Laboratories, up from $430.4 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $741.8 million in Q4 2023 to a low of $430.4 million in Q3 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $572.5 million across 5 years, with a median of $610.8 million in 2021.
  • Biggest five-year swings in Liabilities and Shareholders Equity: skyrocketed 47.02% in 2021 and later plummeted 41.58% in 2024.
  • Year by year, Liabilities and Shareholders Equity stood at $721.7 million in 2021, then decreased by 8.14% to $663.0 million in 2022, then grew by 11.88% to $741.8 million in 2023, then tumbled by 41.58% to $433.3 million in 2024, then rose by 0.35% to $434.8 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for MLAB at $434.8 million in Q4 2025, $430.4 million in Q3 2025, and $435.7 million in Q2 2025.